Immunogenicity of a Monovalent 2009 Influenza A(H1N1) Vaccine in Infants and Children: A Randomized Trial

This article, published in The Journal of the American Medical Association, details a randomized, observer-blind, age-stratified, parallel group study assessing two doses of an inactivated, split-virus 2009 influenza A(H1N1) vaccine in healthy infants and children six months to nine years of age in Australia. Study findings concluded that one dose of vaccine was immunogenic in the study population and vaccine-associated reactions were mild to moderate in severity.

Author(s): Nolan T, McVernon J, Skeljo M, et al.

Published: 2010

  • Visit web page (English)

    (Located at jama.ama-assn.org)

    Citation: Nolan T, McVernon J, Skeljo M, et al. Immunogenicity of a Monovalent 2009 Influenza A(H1N1) Vaccine in Infants and Children: A Randomized Trial. JAMA. 2009;303(1):37-46.